Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Chung

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cell Reports. Medicine|March 9, 2024
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapyMichael St Paul, Samuel D Saibil, Meghan Kates, et al.
Cancer Immunology Research|March 14, 2025
CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor MicroenvironmentDouglas C Chung, Noor Shakfa, Jehan Vakharia, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cell Reports. Medicine|March 9, 2024
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapyMichael St Paul, Samuel D Saibil, Meghan Kates, et al.
Cancer Immunology Research|March 14, 2025
CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor MicroenvironmentDouglas C Chung, Noor Shakfa, Jehan Vakharia, et al.
Pageof 2